These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 9182233

  • 1. [Relative depletion in native vitamin D: a potential risk factor in Algerian hemodialysis patients with radiological evidence of hyperparathyroidism and osteomalacia independent of calcitriolemia].
    Atik A, Ghazali A, Achard JM, Rida Z, Oprisiu R, Brazier M, Leflon P, Gueris J, Morinière P, Sari Z, Fournier A.
    Nephrologie; 1997; 18(2):47-52. PubMed ID: 9182233
    [Abstract] [Full Text] [Related]

  • 2. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Morinière P, Garabedian M, Eastwood J, Fournier A.
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [Abstract] [Full Text] [Related]

  • 3. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 4. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.
    Oprisiu R, Bolosiu H, Boca I, Theodoru C, Elefterescu R, Brazier M, el Esper I, Leflon P, Ledeme C, Fournier A, Heinze V.
    Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Dialysis osteodystrophy. A study involving 94 patients.
    Chan YL, Furlong TJ, Cornish CJ, Posen S.
    Medicine (Baltimore); 1985 Sep; 64(5):296-309. PubMed ID: 3839891
    [Abstract] [Full Text] [Related]

  • 7. [Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis].
    Hottelart C, Bako G, Oprisiu R, Georgita A, Presne C, Sarraj A, Morinière P, el Esper N, Fournier A.
    Nephrologie; 2000 Sep; 21(6):275-82. PubMed ID: 11117106
    [Abstract] [Full Text] [Related]

  • 8. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease.
    Davies M, Heys SE, Selby PL, Berry JL, Mawer EB.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):209-12. PubMed ID: 8989260
    [Abstract] [Full Text] [Related]

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jan; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985 Jan; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 11. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Jan; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 12. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C, Naves Díaz M, Rodríguez García M, Fernández Martín JL, Cannata Andía JB.
    Nefrologia; 2003 Jan; 23 Suppl 2():73-7. PubMed ID: 12778859
    [Abstract] [Full Text] [Related]

  • 13. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G, Charra B, Chazot C.
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [Abstract] [Full Text] [Related]

  • 15. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [Abstract] [Full Text] [Related]

  • 16. Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis.
    Fonseca V, Epstein O, Gill DS, Menon RK, Thomas M, McIntyre N, Dandona P.
    J Clin Endocrinol Metab; 1987 May; 64(5):873-7. PubMed ID: 3494037
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive testing in the diagnosis of osteomalacia.
    Bingham CT, Fitzpatrick LA.
    Am J Med; 1993 Nov; 95(5):519-23. PubMed ID: 7646591
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF, Nagode LA, Steinmeyer CL, Renkes G.
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
    Zitt E, Sprenger-Mähr H, Mündle M, Lhotta K.
    BMC Nephrol; 2015 Aug 04; 16():128. PubMed ID: 26238347
    [Abstract] [Full Text] [Related]

  • 20. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb 04; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.